We also demonstrated that the KRT14 and KRT6A expression was elevated in basal cells from patients with mild COVID-19 but not in healthy or severe COVID-19 patients (Fig. 3E), supporting the potential role of the KRT14pos basal cells in mild disease phenotype. Here, KRT6A is linked to COVID-19.